We are live on ! Find out more
NVAX icon

Novavax
NVAX

153 hedge funds and large institutions have $890M invested in Novavax in 2014 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 54 increasing their positions, 46 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 19

43% more capital invested

Capital invested by funds: $623M → $890M (+$267M)

17% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 46

7% more funds holding

Funds holding: 143 → 153 (+10)

49% less call options, than puts

Call options by funds: $4.23M | Put options by funds: $8.32M

Holders
153
Holders Change
+10
Holders Change %
+6.99%
% of All Funds
4.06%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
32
Increased
54
Reduced
46
Closed
19
Calls
$4.23M
Puts
$8.32M
Net Calls
-$4.09M
Net Calls Change
+$2.4M

Top Buyers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
+$5.14M
2
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$4.95M
3
BFA
BlackRock Fund Advisors
California
+$4.54M
4
Millennium Management
Millennium Management
New York
+$4.18M
5
Prudential Financial
Prudential Financial
New Jersey
+$4.12M

Top Sellers

Rank Fund Capital Flow
1
CCM
Camber Capital Management
Massachusetts
-$14.4M
2
RCM
RA Capital Management
Massachusetts
-$9.54M
3
First Eagle Investment Management
First Eagle Investment Management
New York
-$2.08M
4
Ameriprise
Ameriprise
Minnesota
-$1.83M
5
State Street
State Street
Massachusetts
-$1.75M

NVAX Hedge Fund Activity: Q4 2014 in Review

153 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q4 2014, worth a combined $890M — up 43% from $623M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new NVAX positions and 19 closed out — a net gain of 13 holders — while 54 added to existing stakes and 46 trimmed.

The largest buyer was Invesco, adding an estimated $5.14M. The largest seller was Camber Capital Management, cutting an estimated $14.4M.

  • 153 institutional investors held Novavax (NVAX) as of Q4 2014, up from 143 in Q3 2014.
  • Funds reported $890M of Novavax stock for Q4 2014, up 43% quarter-over-quarter.
  • 32 funds opened new Novavax positions in Q4 2014 and 19 closed out, a net change of +13 holders.
  • The largest Novavax buyer in Q4 2014 was Invesco, an estimated $5.14M added.
  • The largest Novavax seller in Q4 2014 was Camber Capital Management, an estimated $14.4M sold.

Based on aggregated 13F filings for Q4 2014.